Enhanced dual contrast agent, Co2+-doped NaYF4: YB3+,Tm3+ nanorods, for near infrared-to-near infrared upconversion luminescence and magnetic resonance imaging

Biomaterials

Volumn 35, Issue 33, 2014, Pages 9167-9176

  Xia, Ao ^a,b   Zhang, Xiaofeng ^a   Zhang, Jun ^a   Deng, Yunyun ^a   Chen, Qiang ^b   Wu, Shishan ^b   Huang, Xiaohua ^a   Shen, Jian ^a,b  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Lanthanide nanoparticle; Magnetic resonance imaging; Multi modality imaging; Nanorod; Rare earth nanomaterials; Upconversion luminescence

Indexed keywords

INFRARED DEVICES; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; MULTILAYERS; NANOPARTICLES; RARE EARTH ELEMENTS; RARE EARTHS;

DUAL-MODALITY IMAGING; HISTOLOGICAL ANALYSIS; INFRARED UP-CONVERSION; LANTHANIDE NANOPARTICLES; MULTI-MODALITY IMAGING; RARE EARTH FLUORIDE NANOPARTICLES; RARE-EARTH NANOMATERIALS; UP-CONVERSION LUMINESCENCE;

NANORODS;

CHITOSAN; COBALT; CONTRAST MEDIUM; LANTHANIDE; NANOMATERIAL; NANOPARTICLE; NANOROD; YTTERBIUM; NANOTUBE; O-CARBOXYMETHYLCHITOSAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DIFFUSION WEIGHTED IMAGING; ENDOCYTOSIS; HISTOLOGY; IMAGING; LUMINESCENCE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMISTRY; FEMALE; HEPG2 CELL LINE; HUMAN; NEAR INFRARED SPECTROSCOPY; NUDE MOUSE; PROCEDURES; TOXICITY TESTING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; CONTRAST MEDIA; FEMALE; HEP G2 CELLS; HUMANS; LANTHANOID SERIES ELEMENTS; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; NANOPARTICLES; NANOTUBES; SPECTROSCOPY, NEAR-INFRARED; TOXICITY TESTS;

EID: 84906781083     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.031     Document Type: Article

References (42)

1. Greco F., Cadeddu J.A., Gill I.S., Kaouk J.H., Remzi M., Thompson R.H., et al. Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers. Eur Urol 2014, 65:947-964.
2. Zhong R., Pytynia M., Pelizzari C., Spiotto M. Bioluminescent imaging of hpv-positive oral tumor growth and its response to image-guided radiotherapy. Cancer Res 2014, 74:2073-2081.
3. de Vries I.J.M., Lesterhuis W.J., Barentsz J.O., Verdijk P., van Krieken J.H., Boerman O.C., et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005, 23:1407-1413.
4. Lehman C.D., Gatsonis C., Kuhl C.K., Hendrick R.E., Pisano E.D., Hanna L., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. NEngl J Med 2007, 356:1295-1303.
5. Gilad A.A., McMahon M.T., Walczak P., Winnard P.T., Raman V., van Laarhoven H.W.M., et al. Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 2007, 25:217-219.
6. Vaijayanthimala V., Cheng P.Y., Yeh S.H., Liu K.K., Hsiao C.H., Chao J.I., et al. The long-term stability and biocompatibility of fluorescent nanodiamond as an invivo contrast agent. Biomaterials 2012, 33:7794-7802.
7. Louie A.Y. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
8. y nanocrystals for dual-modality T2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node. Biomaterials 2011, 32:7200-7208.
9. Cheng L., Wang C., Ma X.X., Wang Q.L., Cheng Y., Wang H., et al. Multifunctional upconversion nanoparticles for dual-modal imaging-guided stem cell therapy under remote magnetic control. Adv Funct Mater 2013, 23:272-280.
10. Ni D.L., Zhang J.W., Bu W.B., Xing H.Y., Han F., Xiao Q.F., et al. Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. ACS Nano 2014, 8:1231-1242.
11. Chen F., Zhang S., Bu W., Liu X., Chen Y., He Q., et al. A"neck-formation" strategy for an antiquenching magnetic/upconversion fluorescent bimodal cancer probe. Chem - Eur J 2010, 16:11254-11260.
12. 2 core-shell nanocubes: novel bimodal contrast agents for MRI and optical imaging. Sci Rep 2013, 3:7.
13. Zhou J., Sun Y., Du X.X., Xiong L.Q., Hu H., Li F.Y. Dual-modality invivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
14. 4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance. Biomaterials 2012, 33:5394-5405.
15. Lee J.E., Lee N., Kim H., Kim J., Choi S.H., Kim J.H., et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. JAm Chem Soc 2010, 132:552-557.
16. Lee D.E., Koo H., Sun I.C., Ryu J.H., Kim K., Kwon I.C. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 2012, 41:2656-2672.
17. Xie J., Lee S., Chen X.Y. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010, 62:1064-1079.
18. Liu J.L., Liu Y., Liu Q., Li C.Y., Sun L.N., Li F.Y. Iridium(III) complex-coated nanosystem for ratiometric upconversion luminescence bioimaging of cyanide anions. JAm Chem Soc 2011, 133:15276-15279.
19. Cheng L., Yang K., Li Y.G., Chen J.H., Wang C., Shao M.W., et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew Chem-Int Ed 2011, 50:7385-7390.
20. Feng W., Zhu X.J., Li F.Y. Recent advances in the optimization and functionalization of upconversion nanomaterials for invivo bioapplications. NPG Asia Mater 2013, 5:15.
21. 4 nanocrystals as potential optical/magnetic multimodal bioprobes. JAm Chem Soc 2012, 134:1323-1330.
22. Yang H., Zhuang Y.M., Sun Y., Dai A.T., Shi X.Y., Wu D.M., et al. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials 2011, 32:4584-4593.
23. 4 core/shell nanocrystals with near-infrared to near-infrared upconversion photoluminescence and magnetic resonance properties. Nanoscale 2011, 3:2003-2008.
24. Sun Y., Zhu X.J., Peng J.J., Li F.Y. Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging. ACS Nano 2013, 7:11290-11300.
25. Li L.L., Zhang R.B., Yin L.L., Zheng K.Z., Qin W.P., Selvin P.R., et al. Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes. Angew Chem-Int Ed 2012, 51:6121-6125.
26. Ong L.C., Ang L.Y., Alonso S., Zhang Y. Bacterial imaging with photostable upconversion fluorescent nanoparticles. Biomaterials 2014, 35:2987-2998.
27. 4-based upconversion nanophosphors for high-contrast bioimaging in different animal species. Biomaterials 2012, 33:3733-3742.
28. 153Sm nanoparticles for blood pool imaging invivo. Biomaterials 2013, 34:9535-9544.
29. 4 upconversion nanoparticles for invitro and deeper invivo bioimaging without overheating irradiation. ACS Nano 2011, 5:3744-3757.
30. Cao T., Yang Y., Gao Y., Zhou J., Li Z., Li F. High-quality water-soluble and surface-functionalized upconversion nanocrystals as luminescent probes for bioimaging. Biomaterials 2011, 32:2959-2968.
31. Chen H.Y., Qi B., Moore T., Colvin D.C., Crawford T., Gore J.C., et al. Synthesis of brightly pegylated luminescent magnetic upconversion nanophosphors for deep tissue and dual MRI imaging. Small 2014, 10:160-168.
32. 4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts invivo. ACS Nano 2013, 7:330-338.
33. 4-based upconversion nanophosphors with long-term validity for multimodal lymphatic imaging. Biomaterials 2012, 33:6201-6210.
34. Bu L.H., Xie J., Chen K., Huang J., Aguilar Z.P., Wang A., et al. Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. Contrast Media Mol Imaging 2012, 7:363-372.
35. Sabbioni E., Fortaner S., Farina M., Del Torchio R., Olivato I., Petrarca C., et al. Cytotoxicity and morphological transforming potential of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts: an invitro model. Nanotoxicology 2014, 8:455-464.
36. Wang F., Han Y., Lim C.S., Lu Y.H., Wang J., Xu J., et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463:1061-1065.
37. Li Z., Zhang Y., Jiang S. Multicolor core/shell-structured upconversion fluorescent nanoparticles. Adv Mater 2008, 20:4765-4769.
38. George M., Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. JControl Release 2006, 114:1-14.
39. 4 nanocrystals. Adv Mater 2004, 16:2102-2105.
40. Deddens L.H., Van Tilborg G.A.F., Mulder W.J.M., De Vries H.E., Dijkhuizen R.M. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies. Cerebrovasc Dis 2012, 33:392-402.
41. Kim B., Schmieder A.H., Stacy A.J., Williams T.A., Pan D.P.J. Sensitive biological detection with a soluble and stable polymeric paramagnetic nanocluster. JAm Chem Soc 2012, 134:10377-10380.
42. Chatteriee D.K., Rufalhah A.J., Zhang Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 2008, 29:937-943.